{"id":2963,"date":"2021-04-29T16:52:20","date_gmt":"2021-04-29T16:52:20","guid":{"rendered":"https:\/\/www.africa-press.net\/congo-kinshasa\/politique\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19"},"modified":"2021-04-29T19:47:59","modified_gmt":"2021-04-29T19:47:59","slug":"une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19","title":{"rendered":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19"},"content":{"rendered":"

Africa-Press<\/a> – Congo Kinshasa<\/a>. <\/strong><\/span>L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparasitaire, et le cicl\u00e9sonide, un corticost\u00e9ro\u00efde administr\u00e9 par inhalation pour le traitement des cas l\u00e9gers de COVID-19. L\u2019\u00e9tude clinique ANTICOV est men\u00e9e dans 13 pays africains dont la RDC.<\/p>\n

Ces deux nouveaux compos\u00e9s, disent les chercheurs, poss\u00e8dent des m\u00e9canismes d’action diff\u00e9rents qui pourraient agir \u00e0 diff\u00e9rents stades de l’infection : le premier est potentiellement actif lors de la premi\u00e8re phase de r\u00e9plication du virus SARS-CoV-2, tandis que le deuxi\u00e8me diminue la probabilit\u00e9 d’apparition d\u2019une phase inflammatoire quelques jours plus tard. Ces deux m\u00e9dicaments sont d\u00e9j\u00e0 disponibles sur le march\u00e9 et si leur efficacit\u00e9 contre le COVID-19 est d\u00e9montr\u00e9e, ils offriront l\u2019avantage d\u2019\u00eatre abordables et faciles d’acc\u00e8s et d\u2019administration.<\/p>\n

Les premiers participants de ce nouveau bras de l’\u00e9tude ont \u00e9t\u00e9 recrut\u00e9s en R\u00e9publique d\u00e9mocratique du Congo (RDC) et en R\u00e9publique de Guin\u00e9e. Dans les semaines \u00e0 venir, d’autres sites accueilleront des patients au Burkina Faso, au Cameroun, en C\u00f4te d’Ivoire, en \u00c9thiopie, au Ghana, en Guin\u00e9e \u00e9quatoriale, au Kenya, au Mali, au Mozambique, en Ouganda et au Soudan.<\/p>\n

\u00ab Face \u00e0 un virus qui mute et remet en question les outils dont nous disposons pour le combattre, la recherche de traitements n’a jamais \u00e9t\u00e9 aussi importante. Il est absolument crucial d\u2019identifier les th\u00e9rapies qui pourront \u00eatre ajout\u00e9es \u00e0 l\u2019arsenal de soins existant \u2013 et de d\u00e9terminer comment les adapter au mieux aux environnements \u00e0 faibles ressources \u00bb, a d\u00e9clar\u00e9 le Dr Philippe Duneton, Directeur ex\u00e9cutif d\u2019Unitaid qui finance en partie l\u2019\u00e9tude. \u00ab En soutenant ANTICOV, Unitaid investit dans la recherche de m\u00e9dicaments capables de soigner les formes l\u00e9g\u00e8res et mod\u00e9r\u00e9es de COVID-19 \u2013 une importante faille dans l\u2019arsenal th\u00e9rapeutique actuel, que nous devons combler si nous voulons pr\u00e9venir hospitalisations et d\u00e9c\u00e8s. \u00bb<\/p>\n

L\u2019\u00e9tude ANTICOV est men\u00e9e par un consortium de 26 organisations africaines et institutions internationales de recherche et d\u00e9veloppement de premier plan, coordonn\u00e9es par l\u2019ONG de recherche m\u00e9dicale DNDi (Drugs for Neglected Diseases initiative ou initiative M\u00e9dicaments contre les Maladies N\u00e9glig\u00e9es). C\u2019est la plus vaste \u00e9tude en Afrique \u00e0 avoir pour objectif d\u2019identifier des traitements pr\u00e9coces contre le COVID-19, capables de pr\u00e9venir la progression de la maladie vers une forme s\u00e9v\u00e8re et de potentiellement limiter sa transmission.<\/p>\n

\u00ab Dans de nombreux pays africains, nos pires craintes sont en train de se r\u00e9aliser puisque les unit\u00e9s de soins intensifs d\u00e9j\u00e0 surcharg\u00e9es commencent \u00e0 se remplir de patients atteints du COVID-19 \u00bb, a d\u00e9clar\u00e9 le Dr John Nkengasong, directeur des Centres Africains de Contr\u00f4le et de Pr\u00e9vention des Maladies de l’Union Africaine (CDC Afrique). \u00ab Le continent africain ne re\u00e7oit pourtant pas suffisamment de doses de vaccins. L\u2019efficacit\u00e9 de ceux-ci est en outre menac\u00e9e par la propagation rapide des nouveaux variants, ce qui est un autre sujet majeur d\u2019inqui\u00e9tude. Il est donc urgent d’identifier des traitements abordables et faciles \u00e0 administrer, capables d’emp\u00eacher l’\u00e9volution vers une forme grave de la maladie et de ralentir la propagation de l’infection. \u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"

Africa-Press – Congo Kinshasa. L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparasitaire, et le cicl\u00e9sonide, un corticost\u00e9ro\u00efde administr\u00e9 par inhalation pour le traitement des cas l\u00e9gers de COVID-19. L\u2019\u00e9tude clinique ANTICOV est men\u00e9e dans 13 pays africains dont la RDC. Ces deux nouveaux compos\u00e9s, disent les chercheurs, poss\u00e8dent des […]<\/p>\n","protected":false},"author":82,"featured_media":2962,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,11,10],"tags":[36,47,46],"class_list":["post-2963","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communaute","category-homepage-french","category-toutes-les-actualites","tag-africa-press","tag-africa-press-congo-kinshasa","tag-congo-kinshasa"],"yoast_head":"\nUne nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19 - Congo-kinshasa<\/title>\n<meta name=\"description\" content=\"L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparas ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19\" \/>\n<meta property=\"og:description\" content=\"L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparas ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\" \/>\n<meta property=\"og:site_name\" content=\"Congo-kinshasa\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T16:52:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-29T19:47:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditorfr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditorfr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\"},\"author\":{\"name\":\"cfeditorfr\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"headline\":\"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19\",\"datePublished\":\"2021-04-29T16:52:20+00:00\",\"dateModified\":\"2021-04-29T19:47:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\"},\"wordCount\":591,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg\",\"keywords\":[\"Africa Press\",\"Africa Press-Congo Kinshasa\",\"Congo Kinshasa\"],\"articleSection\":[\"Communaut\u00e9\",\"homepage-french\",\"Toutes les actualit\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\",\"url\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\",\"name\":\"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19 - Congo-kinshasa\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg\",\"datePublished\":\"2021-04-29T16:52:20+00:00\",\"dateModified\":\"2021-04-29T19:47:59+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"description\":\"L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparas ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg\",\"width\":800,\"height\":600,\"caption\":\"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#website\",\"url\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/\",\"name\":\"Congo-kinshasa\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\",\"name\":\"cfeditorfr\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19 - Congo-kinshasa","description":"L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparas ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19","og_locale":"fr_FR","og_type":"article","og_title":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19","og_description":"L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparas ...","og_url":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19","og_site_name":"Congo-kinshasa","article_published_time":"2021-04-29T16:52:20+00:00","article_modified_time":"2021-04-29T19:47:59+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg","type":"image\/jpeg"}],"author":"cfeditorfr","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"cfeditorfr","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19"},"author":{"name":"cfeditorfr","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"headline":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19","datePublished":"2021-04-29T16:52:20+00:00","dateModified":"2021-04-29T19:47:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19"},"wordCount":591,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg","keywords":["Africa Press","Africa Press-Congo Kinshasa","Congo Kinshasa"],"articleSection":["Communaut\u00e9","homepage-french","Toutes les actualit\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19","url":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19","name":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19 - Congo-kinshasa","isPartOf":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg","datePublished":"2021-04-29T16:52:20+00:00","dateModified":"2021-04-29T19:47:59+00:00","author":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"description":"L\u2019\u00e9tude ANTICOV \u00e9value l\u2019efficacit\u00e9 d\u2019un nouveau traitement potentiel associant le nitazoxanide, un m\u00e9dicament antiparas ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#primaryimage","url":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg","contentUrl":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/04\/img-608b0d36d3efa.jpg","width":800,"height":600,"caption":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/une-nouvelle-association-therapeutique-mise-a-lessai-par-anticov-la-plus-vaste-etude-clinique-en-afrique-sur-les-cas-legers-de-covid-19#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africa-press.net\/congo-kinshasa\/"},{"@type":"ListItem","position":2,"name":"Une nouvelle association th\u00e9rapeutique mise \u00e0 l\u2019essai par Anticov, la plus\u00a0vaste\u00a0\u00e9tude clinique\u00a0en Afrique sur les cas l\u00e9gers de COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#website","url":"https:\/\/www.africa-press.net\/congo-kinshasa\/","name":"Congo-kinshasa","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/congo-kinshasa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1","name":"cfeditorfr"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/posts\/2963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/comments?post=2963"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/posts\/2963\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/media\/2962"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/media?parent=2963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/categories?post=2963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/tags?post=2963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}